136 related articles for article (PubMed ID: 3456456)
1. Characterization of human neuroblastoma cell lines established before and after therapy.
Reynolds CP; Biedler JL; Spengler BA; Reynolds DA; Ross RA; Frenkel EP; Smith RG
J Natl Cancer Inst; 1986 Mar; 76(3):375-87. PubMed ID: 3456456
[TBL] [Abstract][Full Text] [Related]
2. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient.
Sugimoto T; Sawada T; Matsumura T; Kemshead JT; Ishii T; Horii Y; Morioka H; Morita M; Reynolds CP
Cancer Res; 1986 Sep; 46(9):4765-9. PubMed ID: 3731124
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution in a human neuroblastoma.
Feder MK; Gilbert F
J Natl Cancer Inst; 1983 Jun; 70(6):1051-6. PubMed ID: 6574274
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Valent A; Venuat AM; Danglot G; Da Silva J; Duarte N; Bernheim A; Bénard J
Med Pediatr Oncol; 2001 Jan; 36(1):100-3. PubMed ID: 11464856
[TBL] [Abstract][Full Text] [Related]
5. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma.
Pietsch T; Göttert E; Meese E; Blin N; Feickert HJ; Riehm H; Kovacs G
Anticancer Res; 1988; 8(6):1329-33. PubMed ID: 3218965
[TBL] [Abstract][Full Text] [Related]
7. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of human neuroblastoma cell lines.
Schlesinger HR; Gerson JM; Moorhead PS; Maguire H; Hummeler K
Cancer Res; 1976 Sep; 36(9 pt.1):3094-100. PubMed ID: 10079
[TBL] [Abstract][Full Text] [Related]
9. Human neuroblastomas and abnormalities of chromosomes 1 and 17.
Gilbert F; Feder M; Balaban G; Brangman D; Lurie DK; Podolsky R; Rinaldt V; Vinikoor N; Weisband J
Cancer Res; 1984 Nov; 44(11):5444-9. PubMed ID: 6488196
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a human neuroblastoma cell line in tissue culture.
Sekiguchi M; Oota T; Sakakibara K; Inui N; Fujii G
Jpn J Exp Med; 1979 Feb; 49(1):67-83. PubMed ID: 470188
[TBL] [Abstract][Full Text] [Related]
11. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
Lastowska M; Roberts P; Pearson AD; Lewis I; Wolstenholme J; Bown N
Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
[TBL] [Abstract][Full Text] [Related]
12. Human neuroblastoma cell lines that express N-myc without gene amplification.
Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic features of human neuroblastomas and cell lines.
Brodeur GM; Green AA; Hayes FA; Williams KJ; Williams DL; Tsiatis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4678-86. PubMed ID: 6171342
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Keshelava N; Seeger RC; Groshen S; Reynolds CP
Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.
Mrózek K; Tanner SM; Heinonen K; Bloomfield CD
Genes Chromosomes Cancer; 2003 Nov; 38(3):249-52. PubMed ID: 14506699
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human neuroblastoma cell lines that lack N-myc gene amplification.
Wada RK; Seeger RC; Brodeur GM; Slamon DJ; Rayner SA; Tomayko M; Reynolds CP
Prog Clin Biol Res; 1988; 271():57-69. PubMed ID: 3406020
[No Abstract] [Full Text] [Related]
17. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
19. An inducible cell line (Natasha), from a neuroblastoma patient with circulating HSR-positive blasts, expressing neurohormones.
Melino G; Vernole P; Annicchiarico-Petruzzelli M; Stephanou A; Colantoni A; Knight RA; Spagnoli LG; Finazzi-Agro A
Anticancer Res; 1992; 12(4):1199-206. PubMed ID: 1503409
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]